| Χρονικό πλαίσιο | Προβλεπόμενη τιμή | Το παρελθόν | Ιστορικός | Διορατικότητα |
|---|---|---|---|---|
| Αύριο | $1.86 ▲ +2.03% | Χθες | $1.80 ▼ -0.85% | Tomorrow's Coherus Oncology Inc. Common Stock (CHRS) setup is anchored to $1.82 and targets $1.86 (+2.03%). The near-term read is upside; watch $1.87 / $1.77 because daily realized volatility is about 8.00%. |
Tomorrow's Coherus Oncology Inc. Common Stock (CHRS) setup is anchored to $1.82 and targets $1.86 (+2.03%). The near-term read is upside; watch $1.87 / $1.77 because daily realized volatility is about 8.00%. | ||||
| Εβδομάδα | $1.93 ▲ +6.31% | Την περασμένη εβδομάδα | $1.77 ▼ -2.65% | The 7-day Coherus Oncology Inc. Common Stock model moves from $1.77 to $1.93 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.87 / $1.77 matter more than a single tick. |
The 7-day Coherus Oncology Inc. Common Stock model moves from $1.77 to $1.93 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.87 / $1.77 matter more than a single tick. | ||||
| Μήνας | $2.06 ▲ +13.45% | τον περασμένο μήνα | $1.72 ▼ -5.65% | The 1-month Coherus Oncology Inc. Common Stock target is $2.06 (+13.45%), compared with the live reference near $1.82. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Coherus Oncology Inc. Common Stock target is $2.06 (+13.45%), compared with the live reference near $1.82. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| έτος | $2.26 ▲ +24.14% | Πέρυσι | $1.64 ▼ -10.14% | The 1-year Coherus Oncology Inc. Common Stock scenario points to $2.26 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Coherus Oncology Inc. Common Stock scenario points to $2.26 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Χρόνια | $2.72 ▲ +49.20% | 5 Πριν από χρόνια | $1.44 ▼ -20.66% | The 5-year Coherus Oncology Inc. Common Stock view is $2.72 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Coherus Oncology Inc. Common Stock view is $2.72 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Δείκτης | Αξία | Σύνθημα |
|---|---|---|
| Price | $1.82 | Mid |
| Daily Change | -8.54% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 76% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $1.82 | Daily Change | -8.54% |
| Market Cap | $280.68M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.